BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14506698)

  • 1. Pattern of secondary genomic changes in pancreatic tumors of Tgf alpha/Trp53+/- transgenic mice.
    Schreiner B; Baur DM; Fingerle AA; Zechner U; Greten FR; Adler G; Sipos B; Klöppel G; Hameister H; Schmid RM
    Genes Chromosomes Cancer; 2003 Nov; 38(3):240-8. PubMed ID: 14506698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
    Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
    Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci.
    Schreiner B; Greten FR; Baur DM; Fingerle AA; Zechner U; Böhm C; Schmid M; Hameister H; Schmid RM
    Oncogene; 2003 Oct; 22(43):6802-9. PubMed ID: 14555993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.
    Wagner M; Greten FR; Weber CK; Koschnick S; Mattfeldt T; Deppert W; Kern H; Adler G; Schmid RM
    Genes Dev; 2001 Feb; 15(3):286-93. PubMed ID: 11159909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of genetic deletions on the long arm of chromosome 22 in human pancreatic adenocarcinomas.
    Handel-Fernandez ME; Nassiri M; Arana M; Perez MM; Fresno M; Nadji M; Vincek V
    Anticancer Res; 2000; 20(6B):4451-6. PubMed ID: 11205287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
    Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
    Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression.
    Herzog CR; Bodon N; Pittman B; Maronpot RR; Massey TE; Anderson MW; You M; Devereux TR
    Oncogene; 2004 Apr; 23(17):3033-9. PubMed ID: 14755239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of inter-simple sequence repeat PCR to mouse models: assessment of genetic alterations in carcinogenesis.
    Benavides F; Zamisch M; Flores M; Campbell MR; Andrew SE; Angel JM; Licchesi J; Sternik G; Richie ER; Conti CJ
    Genes Chromosomes Cancer; 2002 Dec; 35(4):299-310. PubMed ID: 12378524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
    French JE
    IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-alpha p53+/ mice.
    Aichler M; Algül H; Behne D; Hölzlwimmer G; Michalke B; Quintanilla-Martinez L; Schmidt J; Schmid RM; Brielmeier M
    Carcinogenesis; 2007 Sep; 28(9):2002-7. PubMed ID: 17638921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Amatya VJ; Furonaka O; Tagawa K; Kohno N; Inai K
    Pathol Int; 2004 Jul; 54(7):486-9. PubMed ID: 15189501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
    Boley SE; Anderson EE; French JE; Donehower LA; Walker DB; Recio L
    Cancer Res; 2000 Jun; 60(11):2831-5. PubMed ID: 10850423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice.
    Shi YP; Naik P; Dietrich WF; Gray JW; Hanahan D; Pinkel D
    Genes Chromosomes Cancer; 1997 Jun; 19(2):104-11. PubMed ID: 9172001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
    Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
    Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.
    Smolen GA; Muir B; Mohapatra G; Barmettler A; Kim WJ; Rivera MN; Haserlat SM; Okimoto RA; Kwak E; Dahiya S; Garber JE; Bell DW; Sgroi DC; Chin L; Deng CX; Haber DA
    Cancer Res; 2006 Apr; 66(7):3452-5. PubMed ID: 16585167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of loss of heterozygosity in lymphoma and leukaemia arising in F1 hybrid mice locates a common region of chromosome 4 loss.
    Meijne E; Huiskamp R; Haines J; Moody J; Finnon R; Wilding J; Spanjer S; Bouffler S; Edwards A; Cox R; Silver A
    Genes Chromosomes Cancer; 2001 Aug; 31(4):373-81. PubMed ID: 11433528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.